258 related articles for article (PubMed ID: 12663670)
1. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Hayakawa J; Depatie C; Ohmichi M; Mercola D
J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
[TBL] [Abstract][Full Text] [Related]
2. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
3. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress.
Hayakawa J; Mittal S; Wang Y; Korkmaz KS; Adamson E; English C; Ohmichi M; McClelland M; Mercola D
Mol Cell; 2004 Nov; 16(4):521-35. PubMed ID: 15546613
[TBL] [Abstract][Full Text] [Related]
4. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK.
Sevilla A; Santos CR; Vega FM; Lazo PA
J Biol Chem; 2004 Jun; 279(26):27458-65. PubMed ID: 15105425
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death.
Buschmann T; Yin Z; Bhoumik A; Ronai Z
J Biol Chem; 2000 Jun; 275(22):16590-6. PubMed ID: 10748185
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor ATF2 regulation by the JNK signal transduction pathway.
Gupta S; Campbell D; DĂ©rijard B; Davis RJ
Science; 1995 Jan; 267(5196):389-93. PubMed ID: 7824938
[TBL] [Abstract][Full Text] [Related]
9. The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2.
Baan B; van Dam H; van der Zon GC; Maassen JA; Ouwens DM
Mol Endocrinol; 2006 Aug; 20(8):1786-95. PubMed ID: 16601071
[TBL] [Abstract][Full Text] [Related]
10. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter.
Li H; Wicks WD
Arch Biochem Biophys; 2001 Oct; 394(1):1-12. PubMed ID: 11566021
[TBL] [Abstract][Full Text] [Related]
12. Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small.
Bailey J; Europe-Finner GN
J Mol Endocrinol; 2005 Feb; 34(1):19-35. PubMed ID: 15691875
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.
Read MA; Whitley MZ; Gupta S; Pierce JW; Best J; Davis RJ; Collins T
J Biol Chem; 1997 Jan; 272(5):2753-61. PubMed ID: 9006914
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
15. Involvement of ERKs and mitogen- and stress-activated protein kinase in UVC-induced phosphorylation of ATF2 in JB6 cells.
Zhu F; Zhang Y; Bode AM; Dong Z
Carcinogenesis; 2004 Oct; 25(10):1847-52. PubMed ID: 15192015
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line.
Hayakawa J; Ohmichi M; Kurachi H; Ikegami H; Kimura A; Matsuoka T; Jikihara H; Mercola D; Murata Y
J Biol Chem; 1999 Oct; 274(44):31648-54. PubMed ID: 10531373
[TBL] [Abstract][Full Text] [Related]
17. Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells.
Mc Gee MM; Campiani G; Ramunno A; Nacci V; Lawler M; Williams DC; Zisterer DM
J Biol Chem; 2002 May; 277(21):18383-9. PubMed ID: 11856743
[TBL] [Abstract][Full Text] [Related]
18. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.
Potapova O; Haghighi A; Bost F; Liu C; Birrer MJ; Gjerset R; Mercola D
J Biol Chem; 1997 May; 272(22):14041-4. PubMed ID: 9162025
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity.
Laderoute KR; Mendonca HL; Calaoagan JM; Knapp AM; Giaccia AJ; Stork PJ
J Biol Chem; 1999 Apr; 274(18):12890-7. PubMed ID: 10212278
[TBL] [Abstract][Full Text] [Related]
20. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors.
Fuchs SY; Xie B; Adler V; Fried VA; Davis RJ; Ronai Z
J Biol Chem; 1997 Dec; 272(51):32163-8. PubMed ID: 9405416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]